Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Temporary Equity and Stockholders' Deficiency (Unaudited)

v3.19.1
Condensed Consolidated Statement of Changes in Temporary Equity and Stockholders' Deficiency (Unaudited) - USD ($)
Series B Convertible Redeemable Preferred Stock [Member]
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Balance beginning at Dec. 31, 2017 $ 9,026,824 $ 430,674 $ (14,070) $ 80,902,967 $ (10,795,810) $ (75,544,081) $ (5,020,320)
Balance beginning, shares at Dec. 31, 2017 902,670 43,067,546 4,411        
Common stock issued in satisfaction of 401(k) profit sharing liability $ 1,163 80,236 81,399
Common stock issued in satisfaction of 401(k) profit sharing liability, shares 116,284        
Options and warrants 183,220 183,220
Net loss           (1,425,114) (1,425,114)
Other comprehensive loss         (285,609)   (285,609)
Balance ending at Mar. 31, 2018 $ 9,026,824 $ 431,837 $ (14,070) 81,166,423 (11,081,419) (76,969,195) (6,466,424)
Balance ending, shares at Mar. 31, 2018 902,670 43,183,830 4,411        
Balance beginning at Dec. 31, 2018 $ 9,026,824 $ 467,384 $ (46,355) 83,814,442 (13,110,219) (81,222,499) (10,097,247)
Balance beginning, shares at Dec. 31, 2018 902,670 46,738,533 50,533        
Common stock issued in satisfaction of 401(k) profit sharing liability $ 1,812 61,603 63,415
Common stock issued in satisfaction of 401(k) profit sharing liability, shares 181,185        
Options and warrants 157,994 157,994
Common stock issued for cash $ 25,279 859,471 884,750
Common stock issued for cash, shares 2,527,857        
Net loss (1,400,957) (1,400,957)
Other comprehensive loss 8,339 8,339
Balance ending at Mar. 31, 2019 $ 9,026,824 $ 494,475 $ (46,355) $ 84,893,510 $ (13,101,880) $ (82,623,456) $ (10,383,706)
Balance ending, shares at Mar. 31, 2019 902,670 49,447,575 50,533